The effect of therapeutic anticoagulation with enoxaparin vs prophylactic anticoagulation with unfractionated heparin was assessed in severe COVID-19 patients.
Study authors assessed the relationship between children living in contact with sputum smear-positive tuberculosis patients on DOTS and children getting infected with tuberculosis or tubercular infection.
In settings where acid-fast bacilli pulmonary diseases are suspected, gastric aspirate culture may be helpful for diagnosing Mycobacterium avium complex and M kansasii pulmonary disease.
Patients with interstitial lung disease have an increased risk of severe disease and death associated with COVID-19.
Researchers found limited clinical variability between PIV serotypes and substantial overlap in presenting signs and symptoms for PIV and other etiologies.
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
A National Institutes of Health-led clinical trial evaluating hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) has been halted after a data and safety monitoring board determined that the drug was unlikely to benefit hospitalized patients.
In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.
